Clinical Trial

A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension.

Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
The study is being conducted to evaluate the efficacy and safety of HRS-1780 in participants with uncontrolled hypertension or resistant hypertension. To explore the optimal use of HRS-1780 in participants with uncontrolled hypertension or resistant hypertension。
Trial Details
NCT Number NCT07708441
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Uncontrolled or Resistant Hypertension
Enrollment 914 participants
Start Date 2026-07
Primary Completion 2029-04 (estimated)
Study Completion 2029-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-16